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The number of patients with intracardiac devices, including permanent pacemakers and
implantable cardioverter-defibrillators is increasing. Lead perforation is a recognized
complication which most often occurs during or shortly following pacemaker implanta-
tion. Late lead perforation occurring over 30 days after device insertion is a rare, potentially
life-threatening complication. We present a case of late lead perforation unmasked greater
than eight years after pacemaker implantation by initiation of anticoagulation.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction PPM with a bipolar active-fixation right ventricular (RV) leadThe number of patients with intracardiac devices, including
permanent pacemakers (PPM) and implantable cardioverter-
defibrillators (ICD) is increasing. Lead perforation (LPF) is a
recognized complication which most often occurs during or
shortly following PPM implantation. Late LPF occurring over 30
days after device insertion is a rare, potentially life-
threatening complication. We present a case of late LPF
unmasked greater than eight years after PPM implantation by
initiation of anticoagulation.2. Case
A 74-year-old man with multiple medical comorbidities
including sinus node dysfunction, status-post dual-chamberochester, MN 55905, USA
S. Jaffe).
2013, Cardiological Societ(Medtronic, model 5068-58) implanted 8 years prior presented
to the emergency department with a two week history of left
leg swelling. Lower extremity ultrasound demonstrated
extensive acute deep venous thrombosis. Treatment with
warfarin was initiated after the immediate administration of
low-molecular-weight heparin bridging therapy and he was
discharged home. The following day he awoke with sharp,
nonexertional, central chest pain prompting return to the
emergency department. Vital signswerewithin normal limits.
Electrocardiogram showed normal sinus rhythm with a ven-
tricular rate of 69 beats/minute and low anterolateral forces.
Chest X-ray (Fig. 1) revealed an enlarged cardiac silhouette
and a left-sided chest wall PPM with leads that appeared to be
appropriately positioned. CT pulmonary angiogram was per-
formed which demonstrated no pulmonary embolus; how-
ever, the RV PPM lead was seen to penetrate through the RV. Tel.: þ1 507 284 2511; fax: þ1 507 266 0228.
y of India. All rights reserved.
Fig. 1 e Portable chest X-ray (anterioreposterior view)
showing a mildly enlarged cardiac silhouette and left
pleural effusion. Left chest wall pacemaker is in place with
leads in the right atrium and right ventricle.
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(Fig. 2). Transthoracic echocardiogram revealed a moderate
circumferential pericardial effusion. No extravasation of
agitated saline was seen and there were no features of cardiac
tamponade. Anticoagulationwas discontinued and an inferior
vena cava filter was inserted. Pericardiocentesis was per-
formed draining 610 mL of bloody pericardial fluid. A peri-
cardial catheter was left in situ for 5 days. Device interrogation
showed that the device was set to DDDRmode. AV pacing and
sensing delays were 150 and 120 ms, respectively. The lower
pacing rate was 50 beats per minute, the upper tracking rate
90 beats per minute, and the upper sensing rate 90 beats perFig. 2 e CT angiography of the chest with intravenous
contrast (axial view) demonstrating a moderate amount of
high density pericardial fluid consistent with
hemopericardium. The tip of the right ventricular
pacemaker lead can be seen penetrating the right
ventricular wall at the apex (arrow).minute. RA and RV impedance and pacing threshold were
adequate. The underlying rhythm was sinus bradycardia at
55 beats per minute and the patient was not pacemaker-
dependent. Given his poor functional status and the fact
that there was no loss of capture or change in pacing
threshold, he was managed conservatively without lead
revision. He was discharged with colchicine for pain relief on
day 6. He did well for the next six months until he declined
elective PPM replacement due to low battery. Shortly there-
after, he entered a hospice program and expired.3. Discussion
As the number of patientswith PPMs and ICDs increases, long-
term complications may become more prominent. Although
late LPF can be life-threatening, it is most frequently detected
incidentally in individuals undergoing imaging of the chest for
other reasons. Risk factors for cardiac perforation and/or
effusion immediately following PPM implantation include
concomitant temporary transvenous pacing, recent oral ste-
roid use, low body mass index, older age, longer fluoroscopy
times, and the use of screw-in leads.1
Data from the ACT and OPTIMUM Registries suggest an
overall perforation rate of 0.1e0.8% with PPMs and 0.6e5.2%
with ICDs.2 Lead perforations are classified as acute, subacute
or chronic if they occur within 7 days, between day 7e30 or
greater than 30 days post-procedure, respectively. Although
the vast majority of LPF occur during or shortly following de-
vice implantation, late PPM LPF has been reported in over 40
cases.3 Prior to this present case, the longest delay from im-
plantation to diagnosis was seven years.4 The true incidence
of asymptomatic cardiac perforation may be higher than
previously suspected. Hirschl et al demonstrated a 15%
perforation rate in asymptomatic patients with PPMs or ICDs
based on chest CT evaluations.5 In their patient cohort, atrial
and ICD leads were more likely to cause LPF than ventricular
and PPM leads.5 Our patient had a PPM lead which perforated
his RV, the rarest combination in their series.
Although we are uncertain exactly when our patient’s LPF
occurred, the 97-month delay from implantation to presen-
tation is the longest reported to our knowledge. Most likely
our patient had a long-standing asymptomatic RV perforation
which was unmasked by anticoagulation. The incidence of
hemopericardium in patients with cardiac devices who are
anticoagulated is not well known. Although echocardiogra-
phy was equivocal in visualizing the LPF in our patient, CT
imaging clearly delineated the perforation and may be an
effective adjunct in diagnosing LPF. It is unclear if either
radiographic or echocardiographic screening should be rec-
ommended in patients with cardiac devices who are
commencing anticoagulation but an awareness of the possi-
bility of LPF in this setting is important. Furthermore, the
significance and natural history of asymptomatic LPF is un-
clear and treatment may not be necessary. Further studies
evaluating the long-term outcomes in patients with asymp-
tomatic LPF may be of benefit, particularly in view of the need
for anticoagulation in an increasing number of patients. For
now, clinicians should consider lead complications such as
perforation in all patients with cardiac devices who present
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anticoagulation.
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